Incyte (INCY) Competitors

Incyte (NASDAQ:INCY) and ICON Public (NASDAQ:ICLR) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, community ranking, analyst recommendations, profitability, dividends, valuation and earnings.

Does the media prefer INCY or ICLR?

In the previous week, Incyte had 12 more articles in the media than ICON Public. MarketBeat recorded 28 mentions for Incyte and 16 mentions for ICON Public. Incyte's average media sentiment score of 0.43 beat ICON Public's score of -0.08 indicating that Incyte is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Incyte	9 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral
ICON Public	2 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do analysts recommend INCY or ICLR?

Incyte currently has a consensus price target of $77.16, indicating a potential upside of 8.60%. ICON Public has a consensus price target of $292.45, indicating a potential upside of 43.59%. Given ICON Public's stronger consensus rating and higher probable upside, analysts clearly believe ICON Public is more favorable than Incyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Incyte	1 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.38
ICON Public	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86

Do insiders and institutionals hold more shares of INCY or ICLR?

97.0% of Incyte shares are held by institutional investors. Comparatively, 95.6% of ICON Public shares are held by institutional investors. 17.6% of Incyte shares are held by company insiders. Comparatively, 44.0% of ICON Public shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has preferable valuation and earnings, INCY or ICLR?

ICON Public has higher revenue and earnings than Incyte. ICON Public is trading at a lower price-to-earnings ratio than Incyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Incyte	$3.70B	3.70	$597.60M	$0.14	507.54
ICON Public	$8.12B	2.07	$612.34M	$8.97	22.71

Does the MarketBeat Community favor INCY or ICLR?

Incyte received 603 more outperform votes than ICON Public when rated by MarketBeat users. Likewise, 72.75% of users gave Incyte an outperform vote while only 65.50% of users gave ICON Public an outperform vote.

Company	Underperform	Outperform
Incyte	Outperform Votes 1220 72.75%	Underperform Votes 457 27.25%
ICON Public	Outperform Votes 617 65.50%	Underperform Votes 325 34.50%

Is INCY or ICLR more profitable?

ICON Public has a net margin of 9.00% compared to Incyte's net margin of 0.80%. ICON Public's return on equity of 11.91% beat Incyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Incyte	0.80%	-0.63%	-0.45%
ICON Public	9.00%	11.91%	6.64%

Which has more risk & volatility, INCY or ICLR?

Incyte has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, ICON Public has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.

Summary

ICON Public beats Incyte on 12 of the 19 factors compared between the two stocks.